PubMed Sikiric, P., Seiwerth, S., Rucman, R., Kolenc, D., Vuletic, L.B., Drmic, D., Grgic, T., Strbe, S., Zukanovic, G., Crvenkovic, D., Madzarac, G., Rukavina, I., Sucic, M., Baric, M., Staroveski, M., Zoric, Z., Turkalj, I., & Aralica, G
Moreover, there was a suggestion that the immediate exposure of BPC-157 immediately before the injury may have mitigated the damage in the murine models subjected to a force impulse, typically used to simulate TBI in research
BPC-157 is part of an exploding supplement sales empire as dozens of companies have promoted this stuff on social media
TREATMENT LENGTH A quick, daily self-administered subcutaneous injection
Theoretically yes, but stacking introduces complexity without clear additive benefit unless your hypothesis specifically tests synergy between NNMT inhibition and direct lipolytic stimulation